T1	Participants 669 786	1397 antiretroviral-treatment-naive patients, presenting at 18 clinical trial units with 80 research sites in the USA
T2	Participants 1479 1492	1397 patients
T3	Participants 3011 3044	treatment-naive patients with HIV
